SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation
Status:
Terminated
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if simvastatin improves development and behavior in
patients with Smith Lemli-Opitz syndrome (SLOS) receiving dietary cholesterol
supplementation.